Status:
TERMINATED
A 48 Subject Study Using Non-invasive Multi-Technology Measurements for Early Detection of Ongoing Hemorrhage
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
United States Department of Defense
Ohio State University
Conditions:
Occult Bleeding
Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
Early detection of ongoing hemorrhage (OH) before onset of hemorrhagic shock is a universally acknowledged great unmet need, and particularly important after traumatic injury. Delays in the detection ...
Detailed Description
Hemorrhagic shock remains a leading cause of death on the battlefield as well in civilian communities. Early detection of ongoing hemorrhage before progression to frank shock would allow early interve...
Eligibility Criteria
Inclusion
- Adults 18 years or older
- Patients undergoing liver resection.
- Ability to give informed consent.
Exclusion
- Pre-existing systemic illness, likely to alter systemic cardiovascular response to hemorrhage. Including congestive heart failure, and a paced cardiac rhythm.
- Pregnant
- Prisoner status
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04814810
Start Date
February 1 2021
End Date
April 15 2021
Last Update
January 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210